News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,857 Results
Type
Article (25828)
Company Profile (60)
Press Release (352969)
Section
Business (104225)
Career Advice (449)
Deals (16870)
Drug Delivery (50)
Drug Development (47565)
Employer Resources (47)
FDA (12247)
Job Trends (8431)
News (185836)
Policy (19398)
Tag
Academia (1736)
Alliances (26683)
Alzheimer's disease (777)
Approvals (12276)
Artificial intelligence (143)
Bankruptcy (140)
Best Places to Work (6893)
Breast cancer (155)
Cancer (1138)
Cardiovascular disease (94)
Career advice (406)
Cell therapy (177)
Clinical research (40095)
Collaboration (373)
Compensation (93)
COVID-19 (1479)
C-suite (99)
Data (1169)
Diabetes (143)
Diagnostics (3473)
Earnings (36457)
Events (51192)
Executive appointments (367)
FDA (13008)
Funding (338)
Gene therapy (111)
GLP-1 (361)
Government (3008)
Healthcare (12176)
Infectious disease (1538)
Inflammatory bowel disease (75)
IPO (7029)
Job creations (1837)
Job search strategy (378)
Layoffs (161)
Legal (3625)
Lung cancer (189)
Lymphoma (74)
Manufacturing (83)
Medical device (12810)
Medtech (12813)
Mergers & acquisitions (10071)
Metabolic disorders (355)
Neuroscience (1037)
NextGen: Class of 2025 (3929)
Non-profit (2820)
Northern California (1110)
Obesity (188)
Opinion (67)
Parkinson's disease (73)
Patents (83)
People (34474)
Phase I (11489)
Phase II (17364)
Phase III (14251)
Pipeline (447)
Postmarket research (1668)
Preclinical (3555)
Radiopharmaceuticals (158)
Rare diseases (160)
Real estate (2840)
Regulatory (14012)
Research institute (1603)
Southern California (960)
Startups (2118)
United States (10691)
Vaccines (319)
Weight loss (128)
Date
Today (102)
Last 7 days (438)
Last 30 days (1534)
Last 365 days (19402)
2025 (3027)
2024 (19850)
2023 (22740)
2022 (30685)
2021 (32988)
2020 (32194)
2019 (28414)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (353)
Arizona (104)
Asia (24349)
Australia (3855)
California (2495)
Canada (1063)
China (290)
Colorado (143)
Connecticut (150)
Delaware (88)
Europe (47500)
Florida (448)
Georgia (106)
Illinois (310)
Indiana (195)
Japan (90)
Kansas (69)
Maryland (553)
Massachusetts (1783)
Michigan (97)
Minnesota (240)
New Jersey (913)
New York (785)
North Carolina (498)
Northern California (1110)
Ohio (113)
Pennsylvania (690)
South America (519)
Southern California (960)
Texas (428)
Utah (97)
Washington State (195)
378,857 Results for "lepu medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ADCs
ArriVent Joins Chinese Licensing Trend With Potential $1.2B+ ADC Deal with Lepu
With an eye toward advancing a novel antibody-drug conjugate for gastrointestinal cancers, ArriVent is the latest biopharma player to ink a deal with a Chinese biotech.
January 22, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers
January 22, 2025
·
5 min read
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
Keymed Biosciences Inc., and Lepu Biopharma Co., Ltd, jointly announce a global exclusive licence agreement with AstraZeneca for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate.
February 23, 2023
·
3 min read
Press Releases
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
January 9, 2025
·
2 min read
Press Releases
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
October 28, 2024
·
3 min read
News
Tenon Medical(R) Announces Issuance of Three U.S. Patents
October 18, 2024
·
4 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA
PuyouhengTM (HX-008, pucotenlimab injection), was conditionally approved by the National Medical Products Administration (NMPA) for marketing in China to treat patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors, specifically.
July 25, 2022
·
5 min read
Press Releases
Spectra Medical, XL Precision Technologies Announce Rebrand as Elevaris Medical Devices
January 28, 2025
·
3 min read
Press Releases
Akeso Received Payment for the Development Collaboration on Tagitanlimab
January 22, 2025
·
1 min read
1 of 37,886
Next
